The well-recognized individual heterogeneity within COPD patients has led to a growing
interest in greater personalization in the approach of these patients. Thus, the treatable traits …

COPD is complex and heterogeneous with respect to its aetiology, clinical presentation,
phenotypes and biological mechanisms. Despite this, COPD is still diagnosed and treated …

The complexity of COPD implies the need to identify groups of patients with similar clinical
characteristics and prognosis or treatment requirements. This is why much attention has …

The study of airway diseases continues to present several challenges for modern medicine.
The different disease presentations with variables and overlapping features may result in a …

The treatable traits approach is based on the recognition that the different clinical
phenotypes of asthma and chronic obstructive airways disease (COPD) are a …

For decades, chronic obstructive pulmonary disease (COPD) has been considered a
relentlessly progressive disease in which the deterioration of lung function is associated with …

Asthma and chronic obstructive pulmonary disease (COPD) are two prevalent chronic
airways diseases. Both are complex and heterogeneous. Traditionally, clinical guidelines …

ABSTRACT Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous and
complex disease with great morbidity and mortality. Despite the new developments in the …

Chronic obstructive pulmonary disease (COPD) is a complex disorder and not all patients
respond to all available drugs. The importance of personalized treatment in COPD is …

The management of chronic obstructive pulmonary disease (COPD) has improved
significantly due to advances in therapeutic agents, but it has also become apparent that …